High-level expression of early growth response-1 and association of polymorphism with total IgE and atopy in allergic rhinitis adults
Early growth response-1 (Egr-1) is expressed in human airways and its polymorphisms have been associated with total IgE and atopy in asthmatic patients. We investigated the effects of Chinese-tagging single nucleotide polymorphism (SNP) of Egr-1 and its mRNA expression on allergic rhinitis (AR) trai...
Gespeichert in:
Veröffentlicht in: | Clinica chimica acta 2010-01, Vol.411 (1), p.67-71 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Early growth response-1 (Egr-1) is expressed in human airways and its polymorphisms have been associated with total IgE and atopy in asthmatic patients. We investigated the effects of Chinese-tagging single nucleotide polymorphism (SNP) of
Egr-1 and its mRNA expression on allergic rhinitis (AR) traits.
Among 214 Chinese AR adults and 259 controls, tag SNP −4071 A
→
G was genotyped and mRNA expression in peripheral blood was quantified by real-time PCR.
Egr-1 mRNA expression was significantly higher in patients than controls (median of 0.23
vs 0.15 fold
GAPDH expression;
p
<
0.001). Its expression was not associated with −
4071 polymorphism. However, significant correlations were found between −
4071 A
→
G with increased plasma total IgE (
p
=
0.028) and atopy (
p
=
0.030) in patients. Logistic regression confirmed the association (
p
=
0.034) with age and gender adjusted. Patients homozygous for the A allele had a 2.3-fold and 1.9-fold risks, respectively of having increased plasma total IgE and atopy than those G allele carriers.
We showed high levels of
Egr-1 mRNA expression and demonstrated a significant association of polymorphism with increased plasma total IgE and atopy in AR patients. It may be useful to explore the pharmacogenetics of Egr-1 inhibitors. |
---|---|
ISSN: | 0009-8981 1873-3492 |
DOI: | 10.1016/j.cca.2009.10.005 |